DB16424InvestigationalCell transplant therapies
Allocetra is a novel therapy where billions of early apoptotic cells are infused into the bloodstream of a patient, using the body's own natural regulation mechanisms to rebalance an unbalanced... With infusion, the body's macrophages and dendritic cells can feed on these early apoptotic Allocetra cells and thus result in the macrophages and dendritic cells releasing fewer cytokine alert signals so that the immune system...
What you can answer from here — as of May 28, 2026
Which companies are running trials of Allocetra, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account